We examined the expression of KLF4 in the adriamycin (ADM) nephropathy model, the puromycin aminonucleoside nephropathy model, and the db/db diabetic nephropathy model, and a decrease in KLF4 expression was observed in all models. Here, KLF4 is linked to diabetic kidney disease.